Home Health & Hospice Week

Hospice:

New JAMA Study Indicts For-Profit Hospices

Study highlights fissures within hospice industry. A new article in the Journal of the American Medical Association may give policy- and lawmakers more ammunition to tinker with hospice payment rates. For-profit hospices, compared with nonprofit hospices, had a lower proportion of patients with cancer and a higher proportion of patients with dementia and other noncancer diagnoses, based on 2007 data, says the article in the Feb. 2 issue of JAMA. For-profit hospices' patients had a significantly longer length of stay and received less visits from nurses and social workers, found the study authored by physicians at Beth Israel Deaconess Medical Center, Harvard Medical School. "Compared with nonprofit hospice agencies, for-profit hospice agencies had a higher percentage of patients with diagnoses associated with lower-skilled needs and longer lengths of stay," the study concludes. Non-Profits, For-Profits Face Off The study is making cracks within the hospice industry visible. "The study confirms reports [...]
You’ve reached your limit of free articles. Already a subscriber? Log in.
Not a subscriber? Subscribe today to continue reading this article. Plus, you’ll get:
  • Simple explanations of current healthcare regulations and payer programs
  • Real-world reporting scenarios solved by our expert coders
  • Industry news, such as MAC and RAC activities, the OIG Work Plan, and CERT reports
  • Instant access to every article ever published in Revenue Cycle Insider
  • 6 annual AAPC-approved CEUs
  • The latest updates for CPT®, ICD-10-CM, HCPCS Level II, NCCI edits, modifiers, compliance, technology, practice management, and more

Other Articles in this issue of

Home Health & Hospice Week

View All